The prognostic importance of the BRAF V600E mutation in advanced melanoma remains unclear, with multiple studies having variably linked its presence to survival outcomes (32–35), with a recent meta-analysis demonstrating significant heterogeneity between studies (36). The gene discussed is BRAF; the disease is melanoma.